13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001047859
Total reported value
$73.6M
$73.6M
12 檔
46.0%
The Q4 2025 SEC filing reveals that Paragon Associates & Paragon Associates Ii Joint Venture held a total portfolio value of $73.6M, covering 12 public equity positions.
In Q4 2025, Paragon Associates & Paragon Associates Ii Joint Venture adopted a defensive or profit-taking posture, trimming 6 positions and completely liquidating 1 holdings to manage risk exposure.
In terms of portfolio concentration, the top 5 core holdings (including AEM, CDNA, DMAC) accounted for 46.0% of total reported equity market value during Q4 2025.
Top New Position Initiated
QQQ
市值: $6.1M
Top Position Liquidated / Trimmed
AMG
前期市值: $5.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | AEM | Agnico Eagle Mines LTD | Stock-Materials | 17.48% | -10.58% | -37.63% | |
| 2 | CDNA | Caredx Inc | Stock-Other | 14.60% | -2.80% | -11.76% | |
| 3 | DMAC | Diamedica Therapeutics Inc | Stock-Other | 14.39% | -6.34% | — | |
| 4 | QQQ | Invesco Qqq Trust Series 1 | ETF-Tech | 12.69% | -12.69% | EXIT | |
| 5 | NVGS | Navigator Holdings Ltd. | Stock-Other | 10.74% | -2.87% | -40.00% | |
| 6 | NPKI | Npk International Inc | Stock-Other | 9.85% | -2.47% | -11.11% | |
| 7 | STKL | Sunopta Inc | Stock-Other | 6.28% | +0.80% | +6.67% | |
| 8 | EPSN | Epsilon Energy LTD | Stock-Other | 6.23% | -0.79% | — | |
| 9 | IAUX | I-80 Gold CORP | Stock-Other | 4.53% | +0.63% | — | |
| 10 | IRIX | Iridex CORP | Stock-Other | 2.36% | -0.99% | — | |
| 11 | BELFB | Bel Fuse Inc-cl B | Stock-Other | 0.53% | -0.53% | EXIT | |
| 12 | QTRX | Quanterix CORP | Stock-Other | 0.33% | -0.33% | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | DMAC | Diamedica Therapeutics Inc | +3.7% | — | Unchanged |
| 2 | CDNA | Caredx Inc | +3.6% | -11.76% | Trim |
| 3 | IAUX | I-80 Gold CORP | +2% | — | Unchanged |
| 4 | NPKI | Npk International Inc | +0.8% | -11.11% | Trim |
| 5 | EPSN | Epsilon Energy LTD | +0.4% | — | Unchanged |
| 6 | IRIX | Iridex CORP | +0.3% | — | Unchanged |
| 7 | QTRX | Quanterix CORP | -0.6% | -75.17% | Trim |
| 8 | STKL | Sunopta Inc | -1.6% | +6.67% | Add |
| 9 | BELFB | Bel Fuse Inc-cl B | -2% | -85.00% | Trim |
| 10 | NVGS | Navigator Holdings Ltd. | -3.1% | -40.00% | Trim |
| 11 | AEM | Agnico Eagle Mines LTD | -6.6% | -37.63% | Trim |
| 12 | QQQ | Invesco Qqq Trust Series 1 | — | NEW | New buy |
| 13 | AMG | Affiliated Managers Group | — | EXIT | Sold out |
According to official SEC Form 13F filings, Paragon Associates & Paragon Associates Ii Joint Venture reported a total U.S. public equity portfolio value of $73.6M across 12 disclosed positions in Q4 2025.
During Q4 2025, Paragon Associates & Paragon Associates Ii Joint Venture's top holdings by market value included AEM (17.5%)、CDNA (14.6%)、DMAC (14.4%). The largest single position, AEM, represented 17.5% of total portfolio value.
In Q4 2025, Paragon Associates & Paragon Associates Ii Joint Venture made 9 total portfolio adjustments, initiating 1 new buys, adding to 1 positions, trimming 6 holdings, and fully liquidating 1 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.